{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:38:27Z","timestamp":1762508307396,"version":"3.37.3"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:00:00Z","timestamp":1602979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:00:00Z","timestamp":1602979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11739-020-02526-6","type":"journal-article","created":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T16:02:40Z","timestamp":1603036960000},"page":"61-71","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Anticoagulation in patients with advanced liver disease: an open issue"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6610-7068","authenticated-orcid":false,"given":"Francesco","family":"Violi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Loffredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,18]]},"reference":[{"issue":"3","key":"2526_CR1","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","volume":"69","author":"L Pimpin","year":"2018","unstructured":"Pimpin L, Cortez-Pinto H, Negro F, Corbould E, Lazarus JV, Webber L, Sheron N, EHS Committee (2018) Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J Hepatol 69(3):718\u2013735. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.011","journal-title":"J Hepatol"},{"issue":"4","key":"2526_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1055\/s-0033-1334144","volume":"39","author":"F Violi","year":"2013","unstructured":"Violi F, Ferro D (2013) Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis. Semin Thromb Hemost 39(4):426\u2013433. https:\/\/doi.org\/10.1055\/s-0033-1334144","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"2526_CR3","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/jamainternmed.2015.90","volume":"175","author":"F Violi","year":"2015","unstructured":"Violi F (2015) Should the term coagulopathy in cirrhosis be abandoned? JAMA Intern Med 175(5):862\u2013863. https:\/\/doi.org\/10.1001\/jamainternmed.2015.90","journal-title":"JAMA Intern Med"},{"issue":"6","key":"2526_CR4","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.jhep.2011.06.008","volume":"55","author":"F Violi","year":"2011","unstructured":"Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK (2011) Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 55(6):1415\u20131427. https:\/\/doi.org\/10.1016\/j.jhep.2011.06.008","journal-title":"J Hepatol"},{"issue":"1","key":"2526_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/ijlh.12934","volume":"41","author":"MF Ruberto","year":"2019","unstructured":"Ruberto MF, Marongiu F, Sorbello O, Civolani A, Demelia L, Barcellona D (2019) Are prothrombin time and clot waveform analysis useful in detecting a bleeding risk in liver cirrhosis? Int J Lab Hematol 41(1):118\u2013123. https:\/\/doi.org\/10.1111\/ijlh.12934","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"2526_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1055\/s-0038-1655904","volume":"77","author":"F Violi","year":"1997","unstructured":"Violi F, Ferro D, Basili S, Lionetti R, Rossi E, Merli M, Riggio O, Bezzi M, Capocaccia L (1997) Ongoing prothrombotic state in the portal circulation of cirrhotic patients. Thromb Haemost 77(1):44\u201347","journal-title":"Thromb Haemost"},{"issue":"2","key":"2526_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jhep.2013.03.036","volume":"59","author":"A Tripodi","year":"2013","unstructured":"Tripodi A, Primignani M, Lemma L, Chantarangkul V, Mannucci PM (2013) Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis. J Hepatol 59(2):265\u2013270. https:\/\/doi.org\/10.1016\/j.jhep.2013.03.036","journal-title":"J Hepatol"},{"issue":"6","key":"2526_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1055\/s-0038-1642513","volume":"71","author":"MJ Kovacs","year":"1994","unstructured":"Kovacs MJ, Wong A, MacKinnon K, Weir K, Keeney M, Boyle E, Cruickshank M (1994) Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost 71(6):727\u2013730","journal-title":"Thromb Haemost"},{"issue":"2","key":"2526_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2010.01.042","volume":"53","author":"Lisman T, Caldwell SH, Burroughs AK, Northup PG, Senzolo M, Stravitz RT, Tripodi A, Trotter JF, Valla DC, Porte RJ, Coagulation in Liver Disease Study G","year":"2010","unstructured":"Lisman T, Caldwell SH, Burroughs AK, Northup PG, Senzolo M, Stravitz RT, Tripodi A, Trotter JF, Valla DC, Porte RJ, Coagulation in Liver Disease Study G (2010) Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol 53(2):362\u2013371. https:\/\/doi.org\/10.1016\/j.jhep.2010.01.042","journal-title":"J Hepatol"},{"issue":"5","key":"2526_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.dld.2016.02.008","volume":"48","author":"Under the auspices of the Italian Association for the Study of Liver D, the Italian Society of Internal M","year":"2016","unstructured":"Under the auspices of the Italian Association for the Study of Liver D, the Italian Society of Internal M (2016) Hemostatic balance in patients with liver cirrhosis: report of a consensus conference. Dig Liver Dis 48(5):455\u2013467. https:\/\/doi.org\/10.1016\/j.dld.2016.02.008","journal-title":"Dig Liver Dis"},{"issue":"4","key":"2526_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1055\/s-0037-1615058","volume":"79","author":"G Davi","year":"1998","unstructured":"Davi G, Ferro D, Basili S, Iuliano L, Camastra C, Giammarresi C, Santarone S, Rocca B, Landolfi R, Ciabattoni G, Cordova C, Violi F (1998) Increased thromboxane metabolites excretion in liver cirrhosis. Thromb Haemost 79(4):747\u2013751","journal-title":"Thromb Haemost"},{"issue":"2","key":"2526_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/hep.28853","volume":"65","author":"V Raparelli","year":"2017","unstructured":"Raparelli V, Basili S, Carnevale R, Napoleone L, Del Ben M, Nocella C, Bartimoccia S, Lucidi C, Talerico G, Riggio O, Violi F (2017) Low-grade endotoxemia and platelet activation in cirrhosis. Hepatology 65(2):571\u2013581. https:\/\/doi.org\/10.1002\/hep.28853","journal-title":"Hepatology"},{"issue":"10","key":"2526_CR13","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1111\/j.1478-3231.2011.02617.x","volume":"31","author":"Basili S, Raparelli V, Riggio O, Merli M, Carnevale R, Angelico F, Tellan G, Pignatelli P, Violi F, Group C","year":"2011","unstructured":"Basili S, Raparelli V, Riggio O, Merli M, Carnevale R, Angelico F, Tellan G, Pignatelli P, Violi F, Group C (2011) NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation. Liver Int 31(10):1533\u20131540. https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02617.x","journal-title":"Liver Int"},{"issue":"5","key":"2526_CR14","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S0168-8278(96)80143-7","volume":"24","author":"S Basili","year":"1996","unstructured":"Basili S, Ferro D, Leo R, Juliano L, Alessandri C, Cordova C, Violi F (1996) Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis. The CALC Group. Coagulation abnormalities in liver cirrhosis. J Hepatol 24(5):574\u2013580","journal-title":"J Hepatol"},{"issue":"3","key":"2526_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/ajg.2017.457","volume":"113","author":"S Basili","year":"2018","unstructured":"Basili S, Raparelli V, Napoleone L, Talerico G, Corazza GR, Perticone F, Sacerdoti D, Andriulli A, Licata A, Pietrangelo A, Picardi A, Raimondo G, Violi F (2018) Platelet count does not predict bleeding in cirrhotic patients: results from the PRO-LIVER Study. Am J Gastroenterol 113(3):368\u2013375. https:\/\/doi.org\/10.1038\/ajg.2017.457","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"2526_CR16","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1160\/TH16-11-0857","volume":"117","author":"C Nocella","year":"2017","unstructured":"Nocella C, Carnevale R, Bartimoccia S, Novo M, Cangemi R, Pastori D, Calvieri C, Pignatelli P, Violi F (2017) Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production. Thromb Haemost 117(8):1558\u20131570. https:\/\/doi.org\/10.1160\/TH16-11-0857","journal-title":"Thromb Haemost"},{"issue":"5","key":"2526_CR17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1055\/s-0037-1614559","volume":"81","author":"S Basili","year":"1999","unstructured":"Basili S, Merli M, Ferro D, Lionetti R, Rossi E, Riggio O, Valeriano V, Capocaccia L, Violi F (1999) Clotting activation after transjugular intrahepatic portosystemic stent shunt. Thromb Haemost 81(5):711\u2013714","journal-title":"Thromb Haemost"},{"issue":"2","key":"2526_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0016-5085(95)90342-9","volume":"109","author":"F Violi","year":"1995","unstructured":"Violi F, Ferro D, Basili S, Saliola M, Quintarelli C, Alessandri C, Cordova C (1995) Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 109(2):531\u2013539. https:\/\/doi.org\/10.1016\/0016-5085(95)90342-9","journal-title":"Gastroenterology"},{"issue":"9","key":"2526_CR19","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1182\/blood.V93.9.2945.409k29_2945_2950","volume":"93","author":"D Ferro","year":"1999","unstructured":"Ferro D, Basili S, Pratico D, Iuliano L, FitzGerald GA, Violi F (1999) Vitamin E reduces monocyte tissue factor expression in cirrhotic patients. Blood 93(9):2945\u20132950","journal-title":"Blood"},{"issue":"3","key":"2526_CR20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1136\/gut.43.3.428","volume":"43","author":"M Saliola","year":"1998","unstructured":"Saliola M, Lorenzet R, Ferro D, Basili S, Caroselli C, Santo AD, Sallese M, Violi F (1998) Enhanced expression of monocyte tissue factor in patients with liver cirrhosis. Gut 43(3):428\u2013432. https:\/\/doi.org\/10.1136\/gut.43.3.428","journal-title":"Gut"},{"issue":"5","key":"2526_CR21","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jhep.2017.07.002","volume":"67","author":"R Carnevale","year":"2017","unstructured":"Carnevale R, Raparelli V, Nocella C, Bartimoccia S, Novo M, Severino A, De Falco E, Cammisotto V, Pasquale C, Crescioli C, Scavalli AS, Riggio O, Basili S, Violi F (2017) Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells Implications for hypercoagulability in cirrhosis. J Hepatol 67(5):950\u2013956. https:\/\/doi.org\/10.1016\/j.jhep.2017.07.002","journal-title":"J Hepatol"},{"key":"2526_CR22","doi-asserted-by":"crossref","unstructured":"Praktiknjo M, Trebicka J, Carnevale R, Queck A, Ettorre E, Violi F (2019) Von willebrand and factor viii porto-systemic circulation gradient in cirrhosis. Clinical and translational gastroenterology (in press)","DOI":"10.14309\/ctg.0000000000000123"},{"key":"2526_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","volume":"66","author":"XL Zheng","year":"2015","unstructured":"Zheng XL (2015) ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu Rev Med 66:211\u2013225. https:\/\/doi.org\/10.1146\/annurev-med-061813-013241","journal-title":"Annu Rev Med"},{"issue":"7","key":"2526_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s11739-016-1467-x","volume":"11","author":"S Lancellotti","year":"2016","unstructured":"Lancellotti S, Basso M, Veca V, Sacco M, Riccardi L, Pompili M, De Cristofaro R (2016) Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study. Intern Emerg Med 11(7):959\u2013967. https:\/\/doi.org\/10.1007\/s11739-016-1467-x","journal-title":"Intern Emerg Med"},{"issue":"6","key":"2526_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nrgastro.2014.7","volume":"11","author":"S Lemoinne","year":"2014","unstructured":"Lemoinne S, Thabut D, Housset C, Moreau R, Valla D, Boulanger CM, Rautou PE (2014) The emerging roles of microvesicles in liver diseases. Nat Rev Gastroenterol Hepatol 11(6):350\u2013361. https:\/\/doi.org\/10.1038\/nrgastro.2014.7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"2526_CR26","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/hep4.1317","volume":"3","author":"S Basili","year":"2019","unstructured":"Basili S, Carnevale R, Nocella C, Bartimoccia S, Raparelli V, Talerico G, Stefanini L, Romiti GF, Perticone F, Corazza GR, Piscaglia F, Pietrangelo A, Violi F, P-L Collaborators (2019) Serum albumin is inversely associated with portal vein thrombosis in cirrhosis. Hepatol Commun 3(4):504\u2013512. https:\/\/doi.org\/10.1002\/hep4.1317","journal-title":"Hepatol Commun"},{"key":"2526_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fcvm.2019.00017","volume":"6","author":"D Pastori","year":"2019","unstructured":"Pastori D, Menichelli D, Gingis R, Pignatelli P, Violi F (2019) Tailored practical management of patients with atrial fibrillation: a risk factor-based approach. Front Cardiovasc Med 6:17. https:\/\/doi.org\/10.3389\/fcvm.2019.00017","journal-title":"Front Cardiovasc Med"},{"key":"2526_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2019.02.002","author":"D Menichelli","year":"2019","unstructured":"Menichelli D, Ettorre E, Pani A, Violi F, Pignatelli P, Pastori D (2019) Update and unmet needs on the use of nonvitamin K oral anticoagulants for stroke prevention in patients with atrial fibrillation. Curr Probl Cardiol. https:\/\/doi.org\/10.1016\/j.cpcardiol.2019.02.002","journal-title":"Curr Probl Cardiol"},{"issue":"3","key":"2526_CR29","doi-asserted-by":"publisher","first-page":"e002197","DOI":"10.1161\/JAHA.115.002197","volume":"5","author":"SD Pokorney","year":"2016","unstructured":"Pokorney SD, Piccini JP, Stevens SR, Patel MR, Pieper KS, Halperin JL, Breithardt G, Singer DE, Hankey GJ, Hacke W, Becker RC, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, Califf RM, Committee RAS, Investigators, Investigators RASC (2016) Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF. J Am Heart Assoc 5(3):e002197. https:\/\/doi.org\/10.1161\/JAHA.115.002197","journal-title":"J Am Heart Assoc"},{"issue":"23","key":"2526_CR30","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.jacc.2016.09.944","volume":"68","author":"A Gomez-Outes","year":"2016","unstructured":"Gomez-Outes A, Lagunar-Ruiz J, Terleira-Fernandez AI, Calvo-Rojas G, Suarez-Gea ML, Vargas-Castrillon E (2016) Causes of death in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 68(23):2508\u20132521. https:\/\/doi.org\/10.1016\/j.jacc.2016.09.944","journal-title":"J Am Coll Cardiol"},{"key":"2526_CR31","doi-asserted-by":"publisher","first-page":"175628481983223","DOI":"10.1177\/1756284819832237","volume":"12","author":"MT Long","year":"2019","unstructured":"Long MT, Ko D, Arnold LM, Trinquart L, Sherer JA, Keppel SS, Benjamin EJ, Helm RH (2019) Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature. Therap Adv Gastroenterol 12:1756284819832237. https:\/\/doi.org\/10.1177\/1756284819832237","journal-title":"Therap Adv Gastroenterol"},{"issue":"11","key":"2526_CR32","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L, Committees A, Investigators (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365(11):981\u2013992. https:\/\/doi.org\/10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"issue":"22","key":"2526_CR33","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Spinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM, Investigators EA-T (2013) Edoxaban versus warfarin in patients with atrial fibrillation. New Engl J Med 369(22):2093\u20132104. https:\/\/doi.org\/10.1056\/NEJMoa1310907","journal-title":"New Engl J Med"},{"issue":"12","key":"2526_CR34","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, Committee R-LS, Investigators (2009) Dabigatran versus warfarin in patients with atrial fibrillation. New Engl J Med 361(12):1139\u20131151. https:\/\/doi.org\/10.1056\/NEJMoa0905561","journal-title":"New Engl J Med"},{"issue":"10","key":"2526_CR35","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, Investigators RA (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New Engl J Med 365(10):883\u2013891. https:\/\/doi.org\/10.1056\/NEJMoa1009638","journal-title":"New Engl J Med"},{"key":"2526_CR36","doi-asserted-by":"crossref","unstructured":"Pastori D, Sciacqua A, Marcucci R, Farcomeni A, Perticone F, Del Ben M, Angelico F, Pignatelli P, Violi F, group A-As (2019) Prevalence and impact of non-alcoholic fatty liver disease in atrial fibrillation. In collaboration with the ATHERO-AF cohort. Mayo Clinic proceedings (in press)","DOI":"10.1016\/j.mayocp.2019.08.027"},{"issue":"5","key":"2526_CR37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1124\/dmd.117.079624","volume":"46","author":"RG Tirona","year":"2018","unstructured":"Tirona RG, Kassam Z, Strapp R, Ramu M, Zhu C, Liu M, Schwarz UI, Kim RB, Al-Judaibi B, Beaton MD (2018) Apixaban and rosuvas\u2014tatin pharmacokinetics in nonalcoholic fatty liver disease. Drug Metab Dispos 46(5):485\u2013492. https:\/\/doi.org\/10.1124\/dmd.117.079624","journal-title":"Drug Metab Dispos"},{"key":"2526_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijcard.2014.11.183","volume":"180","author":"SJ Lee","year":"2015","unstructured":"Lee SJ, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B (2015) The safety and efficacy of vitamin K antagonist in patients with atrial fibrillation and liver cirrhosis. Int J Cardiol 180:185\u2013191. https:\/\/doi.org\/10.1016\/j.ijcard.2014.11.183","journal-title":"Int J Cardiol"},{"issue":"3","key":"2526_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/CIRCOUTCOMES.113.000817","volume":"7","author":"LM Efird","year":"2014","unstructured":"Efird LM, Mishkin DS, Berlowitz DR, Ash AS, Hylek EM, Ozonoff A, Reisman JI, Zhao S, Jasuja GK, Rose AJ (2014) Stratifying the risks of oral anticoagulation in patients with liver disease. Circ Cardiovasc Qual Outcomes 7(3):461\u2013467. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.113.000817","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2526_CR40","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005307","author":"L Kuo","year":"2017","unstructured":"Kuo L, Chao TF, Liu CJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Chen TJ, Lip GYH, Chen SA (2017) Liver cirrhosis in patients with atrial fibrillation: would oral anticoagulation have a net clinical benefit for stroke prevention? J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.116.005307","journal-title":"J Am Heart Assoc"},{"key":"2526_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13285","author":"A De Gottardi","year":"2016","unstructured":"De Gottardi A, Trebicka J, Klinger C, Plessier A, Seijo S, Terziroli B, Magenta L, Semela D, Buscarini E, Langlet P, Gortzen J, Puente A, Mullhaupt B, Navascues C, Nery F, Deltenre P, Turon F, Engelmann C, Arya R, Caca K, Peck-Radosavljevic M, Leebeek FW, Valla D, Garcia-Pagan JC, Investigators V (2016) Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis. Liver Int. https:\/\/doi.org\/10.1111\/liv.13285","journal-title":"Liver Int"},{"issue":"4","key":"2526_CR42","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/ejh.12844","volume":"98","author":"J Hum","year":"2017","unstructured":"Hum J, Shatzel JJ, Jou JH, Deloughery TG (2017) The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis. Eur J Haematol 98(4):393\u2013397. https:\/\/doi.org\/10.1111\/ejh.12844","journal-title":"Eur J Haematol"},{"issue":"5","key":"2526_CR43","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/ejh.13045","volume":"100","author":"P Goriacko","year":"2018","unstructured":"Goriacko P, Veltri KT (2018) Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation. Eur J Haematol 100(5):488\u2013493. https:\/\/doi.org\/10.1111\/ejh.13045","journal-title":"Eur J Haematol"},{"key":"2526_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijcard.2018.01.097","volume":"264","author":"D Pastori","year":"2018","unstructured":"Pastori D, Lip GYH, Farcomeni A, Del Sole F, Sciacqua A, Perticone F, Marcucci R, Grifoni E, Pignatelli P, Violi F, group A-As (2018a) Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants. Int J Cardiol 264:58\u201363. https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.097","journal-title":"Int J Cardiol"},{"key":"2526_CR45","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.dib.2018.01.109","volume":"17","author":"D Pastori","year":"2018","unstructured":"Pastori D, Lip GYH, Farcomeni A, Del Sole F, Sciacqua A, Perticone F, Marcucci R, Grifoni E, Pignatelli P, Violi F, group A-As (2018b) Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants. Data Brief 17:830\u2013836. https:\/\/doi.org\/10.1016\/j.dib.2018.01.109","journal-title":"Data Brief"},{"issue":"7","key":"2526_CR46","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/hep4.1513","volume":"4","author":"F Violi","year":"2020","unstructured":"Violi F, Vestri A, Menichelli D, Di Rocco A, Pastori D, Pignatelli P (2020) Direct oral anticoagulants in patients with atrial fibrillation and advanced liver disease: an exploratory meta-analysis. Hepatol Commun 4(7):1034\u20131040. https:\/\/doi.org\/10.1002\/hep4.1513","journal-title":"Hepatol Commun"},{"key":"2526_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.thromres.2016.12.008","volume":"150","author":"S Bos","year":"2017","unstructured":"Bos S, Potze W, Siddiqui MS, Boyett SL, Adelmeijer J, Daita K, Lisman T, Sanyal AJ (2017) Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease. Thromb Res 150:41\u201343. https:\/\/doi.org\/10.1016\/j.thromres.2016.12.008","journal-title":"Thromb Res"},{"issue":"16","key":"2526_CR48","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","volume":"39","author":"Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidbuchel H, Group ESCSD","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidbuchel H, Group ESCSD (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 39(16):1330\u20131393. https:\/\/doi.org\/10.1093\/eurheartj\/ehy136","journal-title":"Eur Heart J"},{"issue":"3","key":"2526_CR49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11739-017-1628-6","volume":"12","author":"D Prisco","year":"2017","unstructured":"Prisco D, Ageno W, Becattini C, D\u2019Angelo A, Davi G, De Cristofaro R, Dentali F, Di Minno G, Falanga A, Gussoni G, Masotti L, Palareti G, Pignatelli P, Santi RM, Santilli F, Silingardi M, Tufano A, Violi F, Simi F, SISET (2017) Italian intersociety consensus on DOAC use in internal medicine. Intern Emerg Med 12(3):387\u2013406. https:\/\/doi.org\/10.1007\/s11739-017-1628-6","journal-title":"Intern Emerg Med"},{"issue":"1","key":"2526_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1160\/TH16-10-0782","volume":"117","author":"T Lisman","year":"2017","unstructured":"Lisman T, Violi F (2017) Cirrhosis as a risk factor for venous thrombosis. Thromb Haemost 117(1):3\u20135. https:\/\/doi.org\/10.1160\/TH16-10-0782","journal-title":"Thromb Haemost"},{"key":"2526_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10110450","author":"A Zanetto","year":"2018","unstructured":"Zanetto A, Campello E, Spiezia L, Burra P, Simioni P, Russo FP (2018) Cancer-associated thrombosis in cirrhotic patients with hepatocellular carcinoma. Cancers. https:\/\/doi.org\/10.3390\/cancers10110450","journal-title":"Cancers"},{"issue":"1","key":"2526_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jceh.2014.12.008","volume":"5","author":"YK Chawla","year":"2015","unstructured":"Chawla YK, Bodh V (2015) Portal vein thrombosis. J Clin Exp Hepatol 5(1):22\u201340. https:\/\/doi.org\/10.1016\/j.jceh.2014.12.008","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"2526_CR53","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1053\/j.gastro.2017.04.042","volume":"153","author":"L Loffredo","year":"2017","unstructured":"Loffredo L, Pastori D, Farcomeni A, Violi F (2017) Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis. Gastroenterology 153(2):480-487.e481. https:\/\/doi.org\/10.1053\/j.gastro.2017.04.042","journal-title":"Gastroenterology"},{"issue":"3","key":"2526_CR54","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/apt.13019","volume":"41","author":"A Kumar","year":"2015","unstructured":"Kumar A, Sharma P, Arora A (2015) Review article: portal vein obstruction\u2013epidemiology, pathogenesis, natural history, prognosis and treatment. Aliment Pharmacol Ther 41(3):276\u2013292. https:\/\/doi.org\/10.1111\/apt.13019","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"2526_CR55","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s11739-016-1416-8","volume":"11","author":"F Violi","year":"2016","unstructured":"Violi F, Corazza GR, Caldwell SH, Perticone F, Gatta A, Angelico M, Farcomeni A, Masotti M, Napoleone L, Vestri A, Raparelli V, Basili S (2016) Portal vein thrombosis relevance on liver cirrhosis: Italian venous thrombotic events registry. Intern Emerg Med 11(8):1059\u20131066. https:\/\/doi.org\/10.1007\/s11739-016-1416-8","journal-title":"Intern Emerg Med"},{"issue":"6","key":"2526_CR56","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1159\/000369896","volume":"30","author":"SA Lang","year":"2014","unstructured":"Lang SA, Loss M, Wohlgemuth WA, Schlitt HJ (2014) Clinical management of acute portal\/mesenteric vein thrombosis. Viszeralmedizin 30(6):394\u2013400. https:\/\/doi.org\/10.1159\/000369896","journal-title":"Viszeralmedizin"},{"issue":"2","key":"2526_CR57","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0039-1679934","volume":"39","author":"EM Weinberg","year":"2019","unstructured":"Weinberg EM, Palecki J, Reddy KR (2019) Direct-Acting Oral Anticoagulants (DOACs) in cirrhosis and cirrhosis-associated portal vein thrombosis. Semin Liver Dis 39(2):195\u2013208. https:\/\/doi.org\/10.1055\/s-0039-1679934","journal-title":"Semin Liver Dis"},{"issue":"1","key":"2526_CR58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12916-018-1069-8","volume":"16","author":"X Qi","year":"2018","unstructured":"Qi X, Guo X, Yoshida EM, Mendez-Sanchez N, De Stefano V, Tacke F, Mancuso A, Sugawara Y, Yang SS, Teschke R, Arora A, Valla DC (2018) Transient portal vein thrombosis in liver cirrhosis. BMC Med 16(1):83. https:\/\/doi.org\/10.1186\/s12916-018-1069-8","journal-title":"BMC Med"},{"issue":"27","key":"2526_CR59","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.4254\/wjh.v7.i27.2774","volume":"7","author":"JG Stine","year":"2015","unstructured":"Stine JG, Shah PM, Cornella SL, Rudnick SR, Ghabril MS, Stukenborg GJ, Northup PG (2015) Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: a meta-analysis. World J Hepatol 7(27):2774\u20132780. https:\/\/doi.org\/10.4254\/wjh.v7.i27.2774","journal-title":"World J Hepatol"},{"issue":"4","key":"2526_CR60","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ajg.2012.452","volume":"108","author":"H Maruyama","year":"2013","unstructured":"Maruyama H, Okugawa H, Takahashi M, Yokosuka O (2013) De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol 108(4):568\u2013574. https:\/\/doi.org\/10.1038\/ajg.2012.452","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"2526_CR61","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1053\/j.gastro.2019.01.265","volume":"156","author":"NM Intagliata","year":"2019","unstructured":"Intagliata NM, Caldwell SH, Tripodi A (2019) Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology 156(6):1582-1599.e1581. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.265","journal-title":"Gastroenterology"},{"issue":"4","key":"2526_CR62","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","volume":"51","author":"MA Zocco","year":"2009","unstructured":"Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, Riccardi L, Lancellotti S, Santoliquido A, Flore R, Pompili M, Rapaccini GL, Tondi P, Gasbarrini GB, Landolfi R, Gasbarrini A (2009) Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 51(4):682\u2013689. https:\/\/doi.org\/10.1016\/j.jhep.2009.03.013","journal-title":"J Hepatol"},{"issue":"3","key":"2526_CR63","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1053\/j.gastro.2018.01.021","volume":"154","author":"F Violi","year":"2018","unstructured":"Violi F, Pastori D, Farcomeni A, Loffredo L (2018) Reply. Gastroenterology 154(3):761-762.e761. https:\/\/doi.org\/10.1053\/j.gastro.2018.01.021","journal-title":"Gastroenterology"},{"issue":"3","key":"2526_CR64","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1055\/s-0038-1676981","volume":"119","author":"F Violi","year":"2019","unstructured":"Violi F, Corazza GR, Caldwell SH, Talerico G, Romiti GF, Napoleone L, Perticone F, Bolondi L, Pietrangelo A, Vestri AR, Raparelli V, Basili S (2019) Incidence and recurrence of portal vein thrombosis in cirrhotic patients. Thromb Haemost 119(3):496\u2013499. https:\/\/doi.org\/10.1055\/s-0038-1676981","journal-title":"Thromb Haemost"},{"issue":"2","key":"2526_CR65","doi-asserted-by":"publisher","first-page":"154","DOI":"10.14218\/JCTH.2018.00057","volume":"7","author":"M Wu","year":"2019","unstructured":"Wu M, Schuster M, Tadros M (2019) Update on management of portal vein thrombosis and the role of novel anticoagulants. J Clin Transl Hepatol 7(2):154\u2013164. https:\/\/doi.org\/10.14218\/JCTH.2018.00057","journal-title":"J Clin Transl Hepatol"},{"issue":"5","key":"2526_CR66","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/hep.28466","volume":"63","author":"C Noronha Ferreira","year":"2016","unstructured":"Noronha Ferreira C, Seijo S, Plessier A, Silva-Junior G, Turon F, Rautou PE, Baiges A, Bureau C, Bosch J, Hernandez-Gea V, Valla D, Garcia-Pagan JC (2016) Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis. Hepatology 63(5):1640\u20131650. https:\/\/doi.org\/10.1002\/hep.28466","journal-title":"Hepatology"},{"issue":"7","key":"2526_CR67","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s004320050189","volume":"124","author":"M Pirisi","year":"1998","unstructured":"Pirisi M, Avellini C, Fabris C, Scott C, Bardus P, Soardo G, Beltrami CA, Bartoli E (1998) Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J Cancer Res Clin Oncol 124(7):397\u2013400. https:\/\/doi.org\/10.1007\/s004320050189","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2526_CR68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/1358863X15611224","volume":"21","author":"AM Sharma","year":"2016","unstructured":"Sharma AM, Zhu D, Henry Z (2016) Portal vein thrombosis: when to treat and how? Vasc Med 21(1):61\u201369. https:\/\/doi.org\/10.1177\/1358863X15611224","journal-title":"Vasc Med"},{"issue":"2","key":"2526_CR69","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMoa025313","volume":"349","author":"AY Lee","year":"2003","unstructured":"Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349(2):146\u2013153. https:\/\/doi.org\/10.1056\/NEJMoa025313","journal-title":"N Engl J Med"},{"key":"2526_CR70","doi-asserted-by":"publisher","first-page":"8432781","DOI":"10.1155\/2018\/8432781","volume":"2018","author":"P Priyanka","year":"2018","unstructured":"Priyanka P, Kupec JT, Krafft M, Shah NA, Reynolds GJ (2018) Newer oral anticoagulants in the treatment of acute portal vein thrombosis in patients with and without cirrhosis. Int J Hepatol 2018:8432781. https:\/\/doi.org\/10.1155\/2018\/8432781","journal-title":"Int J Hepatol"},{"issue":"2","key":"2526_CR71","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11739-014-1163-7","volume":"10","author":"X Qi","year":"2015","unstructured":"Qi X, Ren W, Guo X, Fan D (2015) Epidemiology of venous thromboembolism in patients with liver diseases: a systematic review and meta-analysis. Intern Emerg Med 10(2):205\u2013217. https:\/\/doi.org\/10.1007\/s11739-014-1163-7","journal-title":"Intern Emerg Med"},{"issue":"3","key":"2526_CR72","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.thromres.2015.06.033","volume":"136","author":"Y Yang","year":"2015","unstructured":"Yang Y, Zhang XZ, Ng HS, Fong JC, Lee LH (2015) The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital. Thromb Res 136(3):548\u2013551. https:\/\/doi.org\/10.1016\/j.thromres.2015.06.033","journal-title":"Thromb Res"},{"issue":"8","key":"2526_CR73","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1055\/s-0039-1697682","volume":"45","author":"B Bikdeli","year":"2019","unstructured":"Bikdeli B, Jimenez D, Garcia-Tsao G, Barba R, Font C, Diaz-Pedroche MDC, Mazzolai L, Little DHW, Tufano A, Tafur AJ, Siegal D, Lip GYH, Monreal M, Investigators R (2019) Venous thromboembolism in patients with liver cirrhosis: findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) registry. Semin Thromb Hemost 45(8):793\u2013801. https:\/\/doi.org\/10.1055\/s-0039-1697682","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"2526_CR74","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1007\/s10620-011-1582-5","volume":"56","author":"M Ali","year":"2011","unstructured":"Ali M, Ananthakrishnan AN, McGinley EL, Saeian K (2011) Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci 56(7):2152\u20132159. https:\/\/doi.org\/10.1007\/s10620-011-1582-5","journal-title":"Dig Dis Sci"},{"issue":"1","key":"2526_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-9560-9-1","volume":"9","author":"A Aldawood","year":"2011","unstructured":"Aldawood A, Arabi Y, Aljumah A, Alsaadi A, Rishu A, Aldorzi H, Alqahtani S, Alsultan M, Felemban A (2011) The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thromb J 9(1):1. https:\/\/doi.org\/10.1186\/1477-9560-9-1","journal-title":"Thromb J"},{"issue":"9","key":"2526_CR76","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/imj.13766","volume":"48","author":"LS Yang","year":"2018","unstructured":"Yang LS, Alukaidey S, Croucher K, Dowling D (2018) Suboptimal use of pharmacological venous thromboembolism prophylaxis in cirrhotic patients. Inter Med J 48(9):1056\u20131063. https:\/\/doi.org\/10.1111\/imj.13766","journal-title":"Inter Med J"},{"issue":"4","key":"2526_CR77","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.thromres.2013.08.001","volume":"132","author":"C Gomez Cuervo","year":"2013","unstructured":"Gomez Cuervo C, Bisbal Pardo O, Perez-Jacoiste Asin MA (2013) Efficacy and safety of the use of heparin as thromboprophylaxis in patients with liver cirrhosis: a systematic review and meta-analysis. Thromb Res 132(4):414\u2013419. https:\/\/doi.org\/10.1016\/j.thromres.2013.08.001","journal-title":"Thromb Res"},{"issue":"1","key":"2526_CR78","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/0897190015611570","volume":"30","author":"KJ Moorehead","year":"2017","unstructured":"Moorehead KJ, Jeffres MN, Mueller SW (2017) A retrospective cohort analysis of pharmacologic VTE prophylaxis and padua prediction score in hospitalized patients with chronic liver disease. J Pharm Pract 30(1):58\u201363. https:\/\/doi.org\/10.1177\/0897190015611570","journal-title":"J Pharm Pract"},{"issue":"4","key":"2526_CR79","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/phar.1218","volume":"33","author":"SM Barclay","year":"2013","unstructured":"Barclay SM, Jeffres MN, Nguyen K, Nguyen T (2013) Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease. Pharmacotherapy 33(4):375\u2013382. https:\/\/doi.org\/10.1002\/phar.1218","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2526_CR80","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mayocp.2018.07.020","volume":"94","author":"Loffredo L, Arienti V, Vidili G, Cogliati C, Battaglia S, Perri L, Di Giulio R, Bernardini S, Summa ML, Sciacqua A, Perticone F, Boddi M, Di Minno G, Lodigiani C, Pietrangelo A, Farcomeni A, Violi F, Group AS","year":"2019","unstructured":"Loffredo L, Arienti V, Vidili G, Cogliati C, Battaglia S, Perri L, Di Giulio R, Bernardini S, Summa ML, Sciacqua A, Perticone F, Boddi M, Di Minno G, Lodigiani C, Pietrangelo A, Farcomeni A, Violi F, Group AS (2019) Low rate of intrahospital deep venous thrombosis in acutely Ill medical patients: results from the AURELIO study. Mayo Clin Proc 94(1):37\u201343. https:\/\/doi.org\/10.1016\/j.mayocp.2018.07.020","journal-title":"Mayo Clin Proc"},{"key":"2526_CR81","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.thromres.2018.08.011","volume":"170","author":"EW Hoolwerf","year":"2018","unstructured":"Hoolwerf EW, Kraaijpoel N, Buller HR, van Es N (2018) Direct oral anticoagulants in patients with liver cirrhosis: a systematic review. Thromb Res 170:102\u2013108. https:\/\/doi.org\/10.1016\/j.thromres.2018.08.011","journal-title":"Thromb Res"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-020-02526-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-020-02526-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-020-02526-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T20:10:00Z","timestamp":1669234200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-020-02526-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,18]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2526"],"URL":"https:\/\/doi.org\/10.1007\/s11739-020-02526-6","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"type":"print","value":"1828-0447"},{"type":"electronic","value":"1970-9366"}],"subject":[],"published":{"date-parts":[[2020,10,18]]},"assertion":[{"value":"20 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}